Search Within

Paul Hamlin

Formats
  1. Meeting Abstract (183)
  2. Journal Article (101)
  3. Research Letter (7)
  4. Correspondence (1)
  5. Review (1)
Groups
  1. Center for Hematologic Malignancies (293)
  2. Department of Medicine (293)
  3. Hematologic Malignancies, Division of (293)
  4. Lymphoma (293)
  5. Population Sciences Research Program (152)
  6. Survivorship Research (145)

More Groups

People
  1. Andrew Zelenetz (186)
  2. Ariela Noy (144)
  3. Steven Horwitz (139)
  4. Maria Palomba (125)
  5. David Straus (122)
  6. Alison Moskowitz (119)

More People

Years
  1. 2025 (6)
  2. 2024 (24)
  3. 2023 (21)
  4. 2022 (12)
  5. 2021 (17)
  6. 2020 (13)

More Years

Publications
  1. Blood (125)
  2. Journal of Clinical Oncology (38)
  3. Hematological Oncology (15)
  4. Annals of Oncology (12)
  5. British Journal of Haematology (12)
  6. Haematologica (10)

More Publications

Publishers
  1. American Society of Hematology (134)
  2. American Society of Clinical Oncology (40)
  3. Wiley Blackwell (19)
  4. Elsevier Inc. (16)
  5. Oxford University Press (13)
  6. John Wiley & Sons (12)

More Publishers

Results (293)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Hamlin, P. A. Jr; Perales, M. A.; Gerecitano, J.; Horwitz, S. M.; Matasar, M. J.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Final results of phase I/II trial of vorinostat in combination with cyclophosphamide, etoposide, prednisone, and rituximab (R-CVEP) for elderly patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Straus, D. J.; Hamlin, P. A.; Matasar, M. J.; Palomba, M. L.; Drullinsky, P.; Zelenetz, A. D.; Gerecitano, J. F.; Noy, A.; Hamilton, A. M.; Wegner, B.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Evaluation of dual tracer (FLT and FDG) PET imaging as part of risk-adapted therapy for patients with advanced stage diffuse large B cell lymphoma (DLBCL)
    Meeting Abstract

    Moskowitz, C. H.; Schoder, H.; Hamlin, P.; Maragulia, J. C.; Walkley, J.; Zelenetz, A. D.
    Blood (2012)

    Fulltext@MSK | Save
  • Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma
    Journal Article

    Moskowitz, C. H.; Matasar, M. J.; Zelenetz, A. D.; Nimer, S. D.; Gerecitano, J.; Hamlin, P.; Horwitz, S.; Moskowitz, A. J.; Noy, A.; Palomba, L.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • The effect of SGN-75, a novel antibody-drug conjugate (ADC), in treatment of patients with renal cell carcinoma (RCC) or non-Hodgkin lymphoma (NHL): A phase I study
    Meeting Abstract

    Thompson, J. A.; Forero-Torres, A.; Heath, E. I.; Ansell, S. M.; Pal, S. K.; Infante, J. R.; De Vos, S.; Hamlin, P. A.; Zhao, B.; Klussman, K.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Elderly Hodgkin lymphoma At MSKCC From 1994-2008: Characteristics, outcome and risk factor analysis in 133 patients
    Meeting Abstract

    Word, Z. H.; Maragulia, J. C.; Walkley, J.; Smith, D. R.; Hamlin, P.
    Blood (2011)

    Fulltext@MSK | Save
  • Anti-CD22 immunoconjugate inotuzumab ozogamicin plus rituximab followed by stem cell transplantation in relapsed/refractory DLBCL patients: Safety and efficacy
    Meeting Abstract

    Wagner-Johnston, N.; Goy, A.; Rodriguez, M. A.; Ehmann, C.; Hamlin, P.; Radford, J.; Thieblemont, C.; Suh, C.; Sweetenham, J.; Jiang, Y.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Modified SMILE in the treatment of natural killer T-cell lymphoma, nasal and nasal type: A single center US experience
    Meeting Abstract

    Lunnnig, M. A.; Pamer, E.; Wintman, L.; Bhatt, V.; Yahalom, J.; Moskowitz, A. J.; Goldberg, J. D.; Straus, D. J.; Hamlin, P.; Zelenetz, A. D.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Older age and co-morbidities do not predict incidence of dose limiting toxicities in lymphoma phase I trials at MSKCC
    Meeting Abstract

    Ammakkanavar, N. R.; Leon, C. A.; Hamlin, P.
    Blood (2011)

    Fulltext@MSK | Save
  • Testis-isolated mantle cell lymphoma: A unique case
    Journal Article

    Epstein, A. S.; Hedvat, C.; Habib, F.; Hamlin, P.
    Clinical Lymphoma, Myeloma and Leukemia (2011)

    Fulltext@MSK | Save